Skip to main content

Table 1 Clinial characteristics of screened HCC patients

From: Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma

parameters

patients, n(%)

Age (years)

  < 60

163 (67.1%)

  > =60

80 (32.9%)

Gender

 Female,n(%)

69 (28.4%)

 Male,n(%)

174((71.6%)

Grade

 1–2,n(%)

143 (58.8%)

 3–4,n(%)

100 (41.2%)

T grade

 T1–2,n(%)

182 (74.9%))

 T3–4,n(%)

61 (25.1%)

Risk score

 Low,n(%)

123 (50.6%)

 High,n(%)

120 (49.4%)

BMI

  < 24,n(%)

115 (47.3%)

  > =24,n(%)

128 (52.7%)

Race

 Asian,n(%)

126 (51.9%)

 Non-Asian,n(%)

117 (48.1%)

Other Tumor

 No,n(%)

225 (92.6%)

 Yes,n(%)

18 (7.4%)

Cancer status

 Tumor Free,n(%)

162 (66.7%)

 With Tumor,n(%)

81 (33.4%)

HCC risk factor

 No,n(%)

55 (22.6%)

 Yes,n(%)

188 (77.4%)

Surgical method

 Lobectomy,n(%)

94 (38.7%)

 Non-Lobectomy,n(%)

149 (61.3%)

Residual tumor

 R0,n(%)

230 (94.7%)

 No R0,n(%)

13 (5.3%)

New tumor event

 No,n(%)

105 (43.2%)

 Yes,n(%)

138 (56.8%)